Hypertension Control, Still a Cause of Concern in the Elderly Population With Diabetes & Dyslipidemia — A Multicentre Study Across India

Objective: Diabetes patients have a relative risk of cardiovascular disease development that is more than twice as high as non-diabetics. In individuals with type II diabetes, optimal blood pressure management & within-range lipid profiles (lower levels of LDL-C) offer cardiovascular benefits. Diabetes with coexisting hypertension, dyslipidemia, pro-inflammatory, & prothrombic states is an example of a metabolic syndrome that can lead to complicated pathological diseases involving several pathways. This EHR-based real-world study aimed to understand hypertension control in patients with diabetes and dyslipidemia in the Indian population. Design and method: The trial was open to patients with a history of type 2 diabetes mellitus (T2DM) lasting at least 6 months who were presenting for regular treatment in 14 nationwide centers. Data on the patient's medical history, comorbidities, complications from diabetes, medicines, & laboratory results were gathered using an EMR (MEDEVA) integrated research format. The data extracted for analysis spanned from March to August 2022. Results: Of the total 821 elderly Type 2 Diabetes Mellitus patients, 45.3% had hypertension, and 16% patients had dyslipidemia. It is seen that dyslipidemia (81.7%) is higher in patients with hypertension when compared to the group without hypertension (18.3%). Conclusions: There is a significant relationship between hypertension control and dyslipidemia, & it was found that dyslipidemia is seen more among hypertensive patients than non-hypertensive patients.